Comparison of the non-specific binding of unfractionated heparin and low molecular weight heparin (Enoxaparin) to plasma proteins

作者: Edward Young , Benilde Cosmi , Jeffrey Weitz , Jack Hirsh

DOI: 10.1055/S-0038-1649639

关键词:

摘要: The non-specific binding of anticoagulantly-active heparin to plasma proteins may influence its anticoagulant effect. We used low affinity (LAH) essentially devoid anti-factor Xa activity investigate the extent and possible mechanism this binding. addition excess LAH platelet-poor containing a fixed amount unfractionated doubled presumably because it displaces from proteins. Although dextran sulfates varying molecular weights also increased activity, less sulfated heparin-like polysaccharides had no These findings suggest that ability displace active protein sites is related charge be independent size. In contrast effect in heparin, there was little augmentation when added weight (LMWH), indicating LMWH binds than heparin. This concept supported by studies comparing with buffer antithrombin III. 2-fold purified system. contrast, identical both buffer, respectively. clinically relevant recovered 33% lower patients suspected venous thrombosis healthy volunteers.(ABSTRACT TRUNCATED AT 250 WORDS)

参考文章(25)
Gunnar Pejler, Ulf Lindahl, David A. Lane, Elizabeth A. Thompson, Angela M. Flynn, Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4. Journal of Biological Chemistry. ,vol. 261, pp. 3980- 3986 ,(1986) , 10.1016/S0021-9258(17)35610-7
H R Lijnen, M Hoylaerts, D Collen, Heparin binding properties of human histidine-rich glycoprotein. Mechanism and role in the neutralization of heparin in plasma. Journal of Biological Chemistry. ,vol. 258, pp. 3803- 3808 ,(1983) , 10.1016/S0021-9258(18)32737-6
Tereza Bârzu, Pascale Molho, Gérard Tobelem, Maurice Petitou, Jacques Caen, Binding and endocytosis of heparin by human endothelial cells in culture Biochimica et Biophysica Acta. ,vol. 845, pp. 196- 203 ,(1985) , 10.1016/0167-4889(85)90177-6
L.H. Lam, J.E. Silbert, R.D. Rosenberg, The separation of active and inactive forms of heparin Biochemical and Biophysical Research Communications. ,vol. 69, pp. 570- 577 ,(1976) , 10.1016/0006-291X(76)90558-1
L.-O. Andersson, T.W. Barrowcliffe, E. Holmer, E.A. Johnson, G. Söderström, Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasma. Thrombosis Research. ,vol. 15, pp. 531- 541 ,(1979) , 10.1016/0049-3848(79)90159-2
Pieter Schoen, Theo Lindhoux, H. Coenraad Hemker, Ratios of anti-factor Xa to antithrombin activities of heparins as determined in recalcified human plasma. British Journal of Haematology. ,vol. 81, pp. 255- 262 ,(1992) , 10.1111/J.1365-2141.1992.TB08217.X
J. Choay, M. Petitou, J.C. Lormeau, P. Sinaÿ, B. Casu, G. Gatti, Structure-activity relationship in heparin : a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity Biochemical and Biophysical Research Communications. ,vol. 116, pp. 492- 499 ,(1983) , 10.1016/0006-291X(83)90550-8
P. Prandoni, M. Carta, A. Cogo, A. Ruol, M. Vigo, D. Casara, A.W.A. Lensing, H.R. Büller, J.W. ten Cate, Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis The Lancet. ,vol. 339, pp. 441- 445 ,(1992) , 10.1016/0140-6736(92)91054-C